Allurion Technologies CEO Shantanu Gaur Resigns
Allurion Technologies, Inc. stated that Chief Executive Officer and board member Shantanu K. Gaur, M.D. resigned his positions effective immediately on July 17, 2026.
Rhea-AI Filing Summary
Allurion Technologies, Inc. stated that Chief Executive Officer and board member Shantanu K. Gaur, M.D. resigned his positions effective immediately on July 17, 2026. The company reported that his resignation was not the result of any disagreement regarding operations, policies or practices.
The board of directors has not appointed an interim or permanent Chief Executive Officer. Chief Operating Officer Ojas Buch is overseeing day-to-day operations and certain responsibilities previously performed by Dr. Gaur, while his title and compensation arrangements remain unchanged.
Positive
- None.
Negative
- Chief Executive Officer and director resignation with no interim or permanent successor yet appointed may create leadership uncertainty until a new CEO is selected.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
CEO resignation effective date: July 17, 2026
Report signature date: July 23, 2026
Warrant share ratio: 0.00378787 shares of common stock
+1 more
4 metrics
CEO resignation effective date
July 17, 2026
Date Shantanu K. Gaur resigned as Chief Executive Officer and director
Report signature date
July 23, 2026
Date the report was signed by Legal Officer Brendan M. Gibbons
Warrant share ratio
0.00378787 shares of common stock
Each warrant to purchase 0.00378787 shares of Allurion common stock
Warrant exercise price
$3,037.50 per share of common stock
Exercise price for each share underlying the ALUR WS warrants
Key Terms
Emerging growth company, pre-commencement communications, exercise price, board of directors
4 terms
Emerging growth company regulatory
"An issuer that qualifies as an "Emerging growth company" under Rule 12b-2"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
pre-commencement communications regulatory
"Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act"
exercise price financial
"Warrants ... each at an exercise price of $3,037.50 per share of common stock"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
board of directors regulatory
"resignation ... as a member of the Company's board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What executive leadership change did Allurion Technologies (ALUR) report?
Allurion Technologies reported that CEO and director Shantanu K. Gaur, M.D. resigned effective July 17, 2026. His resignation was effective immediately, and the board has not yet appointed an interim or permanent CEO, while the COO has assumed oversight of day-to-day operations.
Did Shantanu Gaur resign from Allurion Technologies (ALUR) due to disagreements?
The company stated that Dr. Gaur’s resignation was not the result of any disagreement with Allurion or its board. It specifically referenced the absence of disagreements regarding the company’s operations, policies or practices in connection with his decision to step down.
Who is overseeing operations at Allurion Technologies (ALUR) after the CEO resignation?
Chief Operating Officer Ojas Buch is overseeing Allurion’s day-to-day operations following Dr. Gaur’s resignation. He has assumed certain responsibilities previously handled by the CEO, while his formal title as COO and his compensation arrangements have not been changed in connection with these duties.
Has Allurion Technologies (ALUR) named a new CEO or interim CEO?
As of this report, Allurion’s board has not appointed an interim or permanent Chief Executive Officer. Instead, the existing Chief Operating Officer is temporarily handling day-to-day operational oversight and some former CEO responsibilities while the board evaluates longer-term leadership arrangements.
When did the CEO resignation at Allurion Technologies (ALUR) take effect?
The resignation of CEO and director Shantanu K. Gaur, M.D. took effect immediately on July 17, 2026. This effective date marks when he ceased serving as Chief Executive Officer and board member, with operational oversight transitioning to the company’s Chief Operating Officer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
